【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Prostate Cancer Market, By Type
5.1 Introduction
5.2 Hormone Sensitive
5.3 Hormone Refractory
6 Global Prostate Cancer Market, By Therapy
6.1 Introduction
6.2 Focal Therapies
6.3 Biologic Therapy
6.4 Cryosurgery
6.5 Immunotherapy
6.5.1 Vaccines
6.6 Therapeutic Vaccines
6.6.1 Provenge (Sipuleucel-T)
6.7 Radiation Therapy
6.7.1 External Beam
6.7.1.1 Stereotactic Body
6.7.1.2 Proton Beam
6.7.1.3 Intensity Modulated
6.7.1.4 3D Conformal
6.7.2 Brachytherapy
6.7.2.1 Temporary
6.7.2.2 Permanent
6.8 Chemotherapy
6.8.1 Vinorelbine
6.8.2 Vinblastine
6.8.3 Taxotere (Docetaxel)
6.8.4 Taxanes
6.8.5 Jevtana (Cabazitaxel)
6.8.6 Etoposide
6.8.7 Cytotoxic Drugs
6.8.8 Carboplatin
6.8.9 Antimetabolites
6.8.10 Anthracyclines
6.8.11 Alkylating Agents
6.9 Surgery
6.9.1 Trans Urethral Resection (TUR)
6.9.2 Radical Prostatectomy
6.9.3 Orchidectomy
6.10 Targeted Therapy
6.10.1 Tyrosine Kinase Inhibitors
6.10.2 Signal Transduction Inhibitor
6.10.3 Monoclonal Antibodies
6.10.4 Apoptosis Inducing Drugs
6.10.5 Angiogenesis Inhibitor
6.11 Bone Metastasis
6.11.1 Zometa (Zoledronic Acid)
6.11.2 Xofigo (Radium 223 Dichloride)
6.11.3 Xgeva (Denosumab)
6.11.4 Alpharadin
6.12 Hormonal Therapy
6.12.1 Aromatase Inhibitors
6.12.2 Estrogen-Receptor Modulators (Serms)
6.12.3 Luteinizing Hormone–Releasing Hormone (LHRH) Analogs
6.12.3.1 Lupron
6.12.3.2 Zoladex
6.12.3.3 Decapeptyl
6.12.3.4 Eligard
6.12.3.5 Vantas
6.12.3.6 Leuplin
6.12.3.7 Trelstar (Triptorelin Pamoate)
6.12.3.8 Firmagon (Degarelix)
6.12.3.9 Casodex (Bicalutamide)
6.12.4 Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists
6.12.4.1 Zytiga
6.12.4.2 Gonax
6.12.4.3 Xtandi (Enzalutamide)
6.12.5 Anti–Androgens
6.12.5.1 Casodex
6.12.5.2 Xtandi or MDV3100
6.12.5.3 Xtandi US or MDV3100
6.12.6 Other Hormonal Therapies
7 Global Prostate Cancer Market, By Diagnostic Technique
7.1 Introduction
7.2 Prostate Specific Antigen Test (PSA)
7.3 Digital Rectal Exam (DRE)
8 Global Prostate Cancer Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Pharmacies
8.5 Specialty Clinics
8.6 Other End Users
9 Global Prostate Cancer Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Astellas, Inc.
11.2 AstraZeneca plc
11.3 Bristol Myers Squibb (BMS)
11.4 Johnson & Johnson
11.5 NOVARTIS
11.6 Sanofi S.A
11.7 TOLMAR Inc.
11.8 Tokai Pharmaceuticals
11.9 Progenics Pharmaceuticals Inc.
11.10 OncoGenex Pharmaceuticals Inc.
11.11 OncBioMune Pharmaceuticals Inc.
11.12 Endo Pharmaceuticals
11.13 Bayer Pharma AG
List of Tables
Table 1 Global Prostate Cancer Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Prostate Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 3 Global Prostate Cancer Market Outlook, By Hormone Sensitive (2016-2026) (US $MN)
Table 4 Global Prostate Cancer Market Outlook, By Hormone Refractory (2016-2026) (US $MN)
Table 5 Global Prostate Cancer Market Outlook, By Therapy (2016-2026) (US $MN)
Table 6 Global Prostate Cancer Market Outlook, By Focal Therapies (2016-2026) (US $MN)
Table 7 Global Prostate Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 8 Global Prostate Cancer Market Outlook, By Cryosurgery (2016-2026) (US $MN)
Table 9 Global Prostate Cancer Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 10 Global Prostate Cancer Market Outlook, By Vaccines (2016-2026) (US $MN)
Table 11 Global Prostate Cancer Market Outlook, By Therapeutic Vaccines (2016-2026) (US $MN)
Table 12 Global Prostate Cancer Market Outlook, By Provenge (Sipuleucel-T) (2016-2026) (US $MN)
Table 13 Global Prostate Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 14 Global Prostate Cancer Market Outlook, By External Beam (2016-2026) (US $MN)
Table 15 Global Prostate Cancer Market Outlook, By Brachytherapy (2016-2026) (US $MN)
Table 16 Global Prostate Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 17 Global Prostate Cancer Market Outlook, By Vinorelbine (2016-2026) (US $MN)
Table 18 Global Prostate Cancer Market Outlook, By Vinblastine (2016-2026) (US $MN)
Table 19 Global Prostate Cancer Market Outlook, By Taxotere (Docetaxel) (2016-2026) (US $MN)
Table 20 Global Prostate Cancer Market Outlook, By Taxanes (2016-2026) (US $MN)
Table 21 Global Prostate Cancer Market Outlook, By Jevtana (Cabazitaxel) (2016-2026) (US $MN)
Table 22 Global Prostate Cancer Market Outlook, By Etoposide (2016-2026) (US $MN)
Table 23 Global Prostate Cancer Market Outlook, By Cytotoxic Drugs (2016-2026) (US $MN)
Table 24 Global Prostate Cancer Market Outlook, By Carboplatin (2016-2026) (US $MN)
Table 25 Global Prostate Cancer Market Outlook, By Antimetabolites (2016-2026) (US $MN)
Table 26 Global Prostate Cancer Market Outlook, By Anthracyclines (2016-2026) (US $MN)
Table 27 Global Prostate Cancer Market Outlook, By Alkylating Agents (2016-2026) (US $MN)
Table 28 Global Prostate Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 29 Global Prostate Cancer Market Outlook, By Trans Urethral Resection (TUR) (2016-2026) (US $MN)
Table 30 Global Prostate Cancer Market Outlook, By Radical Prostatectomy (2016-2026) (US $MN)
Table 31 Global Prostate Cancer Market Outlook, By Orchidectomy (2016-2026) (US $MN)
Table 32 Global Prostate Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 33 Global Prostate Cancer Market Outlook, By Tyrosine Kinase Inhibitors (2016-2026) (US $MN)
Table 34 Global Prostate Cancer Market Outlook, By Signal Transduction Inhibitor (2016-2026) (US $MN)
Table 35 Global Prostate Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) (US $MN)
Table 36 Global Prostate Cancer Market Outlook, By Apoptosis Inducing Drugs (2016-2026) (US $MN)
Table 37 Global Prostate Cancer Market Outlook, By Angiogenesis Inhibitor (2016-2026) (US $MN)
Table 38 Global Prostate Cancer Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
Table 39 Global Prostate Cancer Market Outlook, By Zometa (Zoledronic Acid) (2016-2026) (US $MN)
Table 40 Global Prostate Cancer Market Outlook, By Xofigo (Radium 223 Dichloride) (2016-2026) (US $MN)
Table 41 Global Prostate Cancer Market Outlook, By Xgeva (Denosumab) (2016-2026) (US $MN)
Table 42 Global Prostate Cancer Market Outlook, By Alpharadin (2016-2026) (US $MN)
Table 43 Global Prostate Cancer Market Outlook, By Hormonal Therapy (2016-2026) (US $MN)
Table 44 Global Prostate Cancer Market Outlook, By Aromatase Inhibitors (2016-2026) (US $MN)
Table 45 Global Prostate Cancer Market Outlook, By Estrogen-Receptor Modulators (Serms) (2016-2026) (US $MN)
Table 46 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Analogs (2016-2026) (US $MN)
Table 47 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists (2016-2026) (US $MN)
Table 48 Global Prostate Cancer Market Outlook, By Anti–Androgens (2016-2026) (US $MN)
Table 49 Global Prostate Cancer Market Outlook, By Other Hormonal Therapies (2016-2026) (US $MN)
Table 50 Global Prostate Cancer Market Outlook, By Diagnostic Technique (2016-2026) (US $MN)
Table 51 Global Prostate Cancer Market Outlook, By Prostate Specific Antigen Test (PSA) (2016-2026) (US $MN)
Table 52 Global Prostate Cancer Market Outlook, By Digital Rectal Exam (DRE) (2016-2026) (US $MN)
Table 53 Global Prostate Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 54 Global Prostate Cancer Market Outlook, By Ambulatory Surgical Centers (2016-2026) (US $MN)
Table 55 Global Prostate Cancer Market Outlook, By Hospitals (2016-2026) (US $MN)
Table 56 Global Prostate Cancer Market Outlook, By Pharmacies (2016-2026) (US $MN)
Table 57 Global Prostate Cancer Market Outlook, By Specialty Clinics (2016-2026) (US $MN)
Table 58 Global Prostate Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
【レポート販売概要】
■ タイトル：前立腺がんの世界市場展望2017-20276■ 英文：Prostate Cancer - Global Market Outlook (2017-2026)
■ 発行日：2019年8月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC20FB306
■ 調査対象地域：グローバル
- 全身性強直性間代性発作治療のグローバル臨床試験動向（2014年H2）Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data on the Generalized Tonic-Clonic Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Tonic-Clonic Seizure. It inclu …
- 2014年戦略提言：Gonorrhea診断検査市場The report presents a detailed analysis of the Gonorrhea diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Gonorrhea definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Com …
- 断路器の世界市場2015-2019About disconnect switches Disconnect switches help isolate electrical circuits for inspection and maintenance schedules. They include low, medium, and high-voltage switches. Low-voltage disconnect switches can be mounted on switchboards, panel boards, or wall mounts. Vendors also offer fused or non-fused disconnects, and electrically closed and electrically opened devices. Low-voltage disconnect s …
- Cadwell Laboratories, Inc.：市場シェア分析Cadwell Laboratories, Inc. Market Share Analysis Summary GlobalData’s new report, “Cadwell Laboratories, Inc. Market Share Analysis” provides in-depth information on Cadwell Laboratories, Inc.’s market position in the different medical equipment markets it operates in. The report provides Cadwell Laboratories, Inc. market share information in one key market category – Neurological Diagnostic Equip …
- NxStage Medical, Inc.：市場シェア分析NxStage Medical, Inc. Market Share Analysis Summary GlobalData’s new report, “NxStage Medical, Inc. Market Share Analysis” provides in-depth information on NxStage Medical, Inc.’s market position in the renal dialysis equipment market. The report also provides data and information on the overall competitive landscape within the renal dialysis equipment market. The report is supplemented with globa …
- 世界における電気外科用機器の製品パイプライン動向2015Electrosurgical Devices - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Electrosurgical Devices - Pipeline Review, 2015" provides an overview of Electrosurgical Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major p …
- Italian Hospital Microbiology Testing Market 2014This new report from Venture Planning Group contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian microbiology disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. &nbs …
- ウェアラブル材料の世界市場予測（～2023年）“The wearable materials market is projected to register a CAGR of 15.0%, in terms of value, between 2018 and 2023.” The market size for wearable materials is estimated at USD 1.5 billion in 2018 and is projected to reach USD 2.9 billion by 2023, at a CAGR of 15.0% between 2018 and 2023. The growth of this market is attributed to the increasing demand for low-cost wearables and rising disposable in …
- サードパーティ・バンキング・ソフトウェアの世界市場About Third-party Banking Software A third-party software vendor, unlike the legacy system that is developed by a bank’s own in-house IT staff, develops third-party banking software. Worldwide banks are increasingly becoming dissatisfied with legacy systems. These systems lack innovative functionalities available in the modern systems today. Integration of new functionalities in a legacy system is …
- VCSEL（ビクセル）の世界市場予測VCSELs are a type of lasers in which infrared energy is emitted from the surface cavity of semiconductor layers. Multiple devices can be packaged together to form an array and used for high-speed optical data communication over short distances. Their high reliability and low cost of fabrication have also encouraged manufacturers to develop these devices for sensing applications. In the last few ye …
- 多要素認証（MFA）の世界市場予測Multi-factor authentication is a vast market with a huge scope for growth. The MFA technology plays an important role because it helps to meet legislative compliances, security needs, inter border security requirements, enterprise data securities, and so on. Banking and finance, travel and immigration, defense and cyber security applications are deploying MFA on a large scale. The major drivers of …
- 下痢(Diarrhea)：世界の治験レビュー（2015年上半期版）Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2015" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe …
- 2014年戦略提言：Tuberculosis診断検査市場The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 世界のスマートプランテーション管理システム市場：種類別（灌漑システム、植物成長監視システム、収穫システム）、作物別（コーヒー、油糧種子、サトウキビ、綿）、コンポーネント別（ハードウェア＆ソフトウェア）、地域別“Increase in adoption of plantation intelligence (PI) and data mining by farmers and reduction in the wastage of resources and manpower.” The global smart plantation management systems market size is projected to grow from USD 1.1 billion in 2019 to USD 1.5 billion by 2025, recording a compound annual growth rate (CAGR) of 5.8% during the forecast period. The major factors driving the growth of th …
- 世界の大型トラック市場This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
